A Phase I/II Study of the Safety, Pharmacokinetic Interaction and Efficacy of S-3304 in Combination With Standard Therapy in Patients With Locally Advanced Non-small Cell Lung Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 07 May 2018
At a glance
- Drugs S 3304 (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Shionogi
- 30 Apr 2018 Status changed from active, no longer recruiting to completed.
- 17 Sep 2005 New trial record.